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Abstract
Aims/hypothesis Human brown adipose tissue (BAT) has re-
cently emerged as a potential target in the treatment of type 2
diabetes, owing to its capacity to actively clear glucose from
the circulation—at least upon cold exposure. The effects of
insulin resistance on the capacity of human BAT to take up
glucose are unknown. Prolonged fasting is known to induce
insulin resistance in peripheral tissues in order to spare glu-
cose for the brain.
Methods We studied the effect of fasting-induced insulin
resistance on the capacity of BAT to take up glucose
during cold exposure as well as on cold-stimulated ther-
mogenesis. BAT glucose uptake was assessed by means
of cold-stimulated dynamic 2-deoxy-2-[18F]fluoro-D-glu-
cose positron emission tomography/computed tomogra-
phy ([18F]FDG-PET/CT) imaging.
Results We show that a 54 h fasting period markedly de-
creases both cold-induced BAT glucose uptake and
nonshivering thermogenesis (NST) during cold stimulation.
In vivo molecular imaging and modelling revealed that the
reduction of glucose uptake in BAT was due to impaired
cellular glucose uptake and not due to decreased supply.
Interestingly, decreased BAT glucose uptake upon fasting
was related to a decrease in core temperature during cold
exposure, pointing towards a role for BAT in maintaining
normothermia in humans.
Conclusions/interpretation Cold-stimulated glucose up-
take in BAT is strongly reduced upon prolonged fasting.
When cold-stimulated glucose uptake in BAT is also
reduced under other insulin-resistant states, such as di-
abetes, cold-induced activation of BAT may not be a
valid way to improve glucose clearance by BAT under
such conditions.
Trial registration: www.trialregister.nl NTR3523
Funding: This work was supported by the EU FP7 project
DIABAT (HEALTH-F2-2011-278373 to WDvML) and by
the Netherlands Organization for Scientific Research (TOP
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Abbreviations
BAT Brown adipose tissue
BMR Basal metabolic rate
[18F]FDG 2-deoxy-2-[18F]fluoro-D-glucose
NST Nonshivering thermogenesis
PET/CT Positron emission tomography/computed
tomography
RQ Respiratory quotient
SUV Standardised uptake value
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Brown adipose tissue (BAT) is currently regarded as a poten-
tial target in the prevention and treatment of obesity and type 2
diabetes. BAT in animals appears to have a high metabolic
capacity and is able to actively clear glucose from the circu-
lation [1, 2]. It is now well recognised that BAT is
present and active in human adults [3, 4] and that its
oxidative metabolism contributes to nonshivering ther-
mogenesis (NST) during cold exposure [5].
Several rodent studies have shown that obese diabetic
rodents have an impaired cold tolerance [6–9] associated
with a reduced capacity for NST [6] and reduced BAT
activity [8, 9]. Some of these studies indicated that not
obesity per se, but also insulin resistance contributes
significantly to cold intolerance and reduced BAT activ-
ity [8, 10, 11]. In humans, several studies have recently
shown negative correlations between BAT activity and
adiposity [3, 12, 13] and age [14]. A negative association
between BAT activity and diabetic status, independent of
BMI and age, has also been reported in a retrospective
study [15]. In addition, an impaired thermogenic re-
sponse to mild cold has been found in diabetic women
compared with obese women [16], suggesting a role for
insulin resistance in mediating these impairments.
However, a confounding factor in these studies is that
both obesity and ageing are characterised by reduced
BAT activity, independent of diabetes status.
To address whether insulin resistance is directly involved in
reducing BATactivity and NST, a 48 to 60 h fasting period can
be employed to induce insulin resistance in young, healthy
individuals [17–19]. We have recently shown that this
prolonged fasting leads to a 50% reduction in insulin sensi-
tivity, as determined by the gold standard method,
hyperinsulinaemic–euglycaemic clamp, probably due to in-
creased NEFA levels and/or accumulation of triacylglycerols
in peripheral tissues [18]. As a result, glucose uptake is re-
duced in peripheral tissues – mainly skeletal muscle, which is
responsible for ∼80% of glucose uptake under insulin-
stimulated conditions, such as during a hyperinsulinaemic–
euglycaemic clamp [20]. The physiological relevance of this
peripheral insulin resistance is to spare glucose as a substrate
for the brain. However, whether the capacity to stimulate
glucose uptake into BAT is also reduced under insulin-
resistant conditions is presently unknown. Since BAT relies
on both carbohydrate and lipid oxidation for its heat produc-
tion [21], an impaired glucose uptake under fasting-induced
insulin-resistant conditions would hamper its thermogenic
capacity and could lead to reduced capacity to defend body
temperature upon cold exposure. On the other hand, if
glucose uptake into BAT could be stimulated by cold
exposure under such insulin-resistant conditions, activa-
tion of glucose uptake into BAT by cold exposure or
other means could serve as an interesting target to
increase glucose clearance during insulin resistance.
To evaluate whether glucose uptake into BAT is impaired
during fasting-induced insulin resistance, we here examined
16 young, healthy participants in which BAT glucose uptake
was measured after both baseline and 54 h fasting conditions
using dynamic 2-deoxy-2-[18F]fluoro-D-glucose positron
emission tomography/computed tomography ([18F]FDG-
PET/CT) imaging under cold-stimulated conditions, in the
absence of shivering [22].
Methods
Participants Eight male and eight female participants (age
21.9±3.1 years; BMI 21.3±1.5, kg/m2; fat percentage 20.8±
7.8%) were included in the study. All participants were
screened for medical history and status. Studies were per-
formed between August 2012 and June 2013. All females
were on oral contraceptives (ethinyl estradiol or levo-
norgestrel) and were not measured during their menstru-
ation period. Exclusion criteria included diabetes
mellitus, pregnancy, physical activity more than twice
per week, history of cardiovascular diseases and asthma
or other obstructive pulmonary diseases.
Study design Participants took part in two experimental pro-
tocols: a baseline condition and a fasted condition, in a
randomised crossover design. These conditions both included
a similar experimental day. In the fasted condition, this exper-
imental day was preceded by a 48 h fasting period. A
standardised evening meal was prescribed the day before the
start of each experimental protocol.
For the baseline condition (Fig. 1a), consisting of the
experimental day only, participants came in at 07:00 hours
after an overnight fast and were asked to refrain from heavy
exercise 48 h before the measurements. After arrival, a muscle
biopsy was taken from the vastus lateralis muscle [23], and a
light breakfast (energy content <10% of basal metabolic rate
[BMR]) was given subsequently. Body composition was de-
termined by means of dual x-ray absorptiometry (Discovery
A, Hologic, Bedford,MA, USA). After a 4 h fasting period, an
individualised cooling protocol was performed at 11:45 hours
followed by [18F]FDG-PET/CT scanning (Gemini TF PET-
CT, Philips, Eindhoven, the Netherlands) at 14:30 hours. For
this purpose, a cannula was inserted in the left antecubital vein
for blood sampling during thermoneutral and mild cold con-
ditions and injection of the tracer. Participants swallowed a
telemetric pill (CoreTemp HT150002, HQ, Palmetto, FL,
USA), and iButtons (Maxim Integrated Products, San Jose,
CA, USA) were placed on 14 ISO-defined sites [24] for
measurements of core and skin temperatures, respectively. A
chest strap (Polar T31; Polar, Kempele, Finland) was attached
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for measurement of heart rate and a pressure cuff (MTP,
Medisana, Kerkrade, the Netherlands) was placed on the left
arm for measurement of blood pressure. Laser Doppler probes
were attached for skin perfusion measurements at the ventral
sides of the hand, forearm and hallux, and at the abdomen
halfway between the umbilicus and the left lateral side of the
body (PF5000, Perimed, Järfälla, Sweden) [22]. Shivering
intensity was monitored by electromyography (EMG)
sensors (PASAQ, IDEE, Maastricht, the Netherlands)
placed at vastus lateralis, pectoralis major and latissimus
dorsi muscle [5]. A face-mask was used for continuous
measurement of energy expenditure (EE) by means of
indirect calorimetry (Omnical, IDEE).
For the fasted condition (Fig. 1b), participants came in at
07:00 hours on day 1 after an overnight fast and were given a
light breakfast (energy content <10% of BMR). Subsequently,
participants stayed in a controlled room in our research unit
for 48 h to ensure compliance to the fasting regime (no solid
foods, calorie-free drinks only). They were given the oppor-
tunity for supervised light physical exercise (walking,
stretching) for 30–60 min/day. On day 3, a muscle biopsy
was taken in the morning at 07:15 hours, and the cooling
protocol and [18F]FDG-PET/CT scanning was performed in
the afternoon, similar to the experimental day during the
baseline condition.
Individualised cooling protocol and PET/CT scanning
protocol The cooling and PET/CT scanning protocol was
performed as described previously [22]. Briefly, participants
were wrapped in a water-perfused suit (ThermaWrap
Universal 3166, MTRE Advanced Technologies, Yavne,
Israel) and were measured at thermoneutrality for 45 min.
Hereafter, participants were cooled until a temperature just
above their shivering point and measured for 30 min at this
maximal NST temperature; NST was calculated as the per-
centage increase in energy expenditure above BMR (mea-
sured at thermoneutrality) at a temperature just above the
individual’s shivering temperature. Subsequently, participants
were brought to the PET/CT scanner where imaging started
with a low dose CT scan (120 kV, 30 mAs). Participants were
then injected with 74MBq of [18F]FDG at the start of the PET
scanning protocol. Both a dynamic [22] and static [3] scan (six
to seven bed positions, 6 min per bed position) were acquired
as described previously.
PET analysis PET/CT scans were analysed using PMOD
software (version 3.0, PMOD technologies, Zurich,
Switzerland). Both the researcher (MJW Hanssen) and
an experienced nuclear medicine physician (B. Brans)
interpreted the PET/CT images. Glucose uptake rates in
BAT were determined from the dynamic PET data, as
described previously [22]. Two-tissue compartment
modelling was employed to iteratively derive values for
the individual rate constants K1 to k4 using a nonlinear
least squares method [25], whereby k4 was fixed at zero
(Electronic Supplementary Material [ESM] Fig. 1).
For determination of mean and maximal [18F]FDG uptake
in BAT, expressed as standardised uptake values (SUV):
([18F]FDG uptake [kBq/ml])/(injected dose [kBq]/patient
weight [g]), regions of interest were manually outlined in the
static PET scan [26]. A threshold of 1.5 SUVand Hounsfield
units between −10 and −180 were used to define BAT, as
described previously [26].
Fixed volumes of interest were selected in supraclavicular
BAT, subcutaneous and visceral white adipose tissue (WAT),
skeletal muscle (SM), liver and brain to compare [18F]FDG


































Fig. 1 Study protocols for (a) the
baseline condition and (b) the
fasted condition
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Skeletal muscle mitochondrial isolation and respiration Skeletal
muscle mitochondria were isolated as described previously
[22], with minor modifications. Briefly, a portion (∼200 mg)
of the muscle tissue was immediately placed in ice-cold iso-
lation buffer [22] and minced with precooled scissors follow-
ed by an enzymatic digestion with protease (Subtilisin A,
Sigma Aldrich, St Louis, MO, USA). Muscle pieces were
then centrifuged at 8,500 g for 5 min at 4°C. After removal
of the supernatant fraction, the pellet was resuspended in
isolation buffer and homogenised in a glass potter tube. The
homogenate was transferred to a centrifuge tube and centri-
fuged at 1,000 g for 10 min at 4°C. The resulting supernatant
fraction was filtered through cheesecloth, and centrifuged at
10,000 g for 10 min at 4°C. The resulting mitochondrial pellet
was resuspended in 20 μl isolation buffer, and protein content
was determined by Fluram assay [28]. Subsequently, high-
resolution respirometry on a 2-chamber Oxygraph (Oroboros
Instruments, Innsbruck, Austria) with automatic palmitate
titration was performed, as described previously [22].
Successful mitochondrial respiration measurements were
achieved in 11 participants (six males and five females; base-
line and fasted assays successful).
Blood analysis Plasma concentrations of glucose, free glyc-
erol, total glycerol and NEFAs were determined on a Cobas
FARA centrifugal spectrophotometer (Roche Diagnostics,
Basel, Switzerland), as described previously [26].
Triacylglycerol levels were calculated as the difference be-
tween total and free glycerol. Serum insulin was analysed with
a Human Insulin Specific RIA kit (Millipore, Billerica, MA,
USA) on a gamma counter (2470 Automatic Counter
Wizard2, PerkinElmer, Waltham, MA, USA). Plasma cate-
cholamines were analysed on HPLC and by fluorimetric
detection [29]. Serum thyroid-stimulating hormone
(TSH) and free thyroxine (FT4) were analysed as de-
scribed previously [26].
Statistical analysis Statistical analyses were performed with
SPSS Statistics 20.0 for MAC (IBM, Armonk, NY, USA).
Reported data are expressed as means±SD, unless stated
otherwise. A Shapiro–Wilk test was used to test for normal
distribution of relevant variables and non-parametric tests
were used when appropriate. Two-sided paired sample t tests
were used to compare findings between baseline and fasted
conditions and between thermoneutral and mild cold condi-
tions. Two-sided independent sample t tests were used to
compare findings between men and women. Pearson correla-
tions were used to identify correlations between variables. The
level of statistical significance was set at p<0.05.
Study approval The Ethics Committee of Maastricht
University Medical Centre+ approved the study protocol
and all participants provided written informed consent.
Procedures were conducted according to the principles of
the Declaration of Helsinki.
Results
Effect of fasting on plasma variables NEFA levels were mark-
edly higher after fasting compared with the baseline condition
(1,172±284 vs 600±221 μmol/l, respectively; p<0.001;
Table 1), and plasma glucose (5.0±0.3 vs 3.9±0.5 mmol/l,
baseline vs fasted, respectively; p<0.001) and insulin (51.4±
22.9 vs 38.9±16.7 pmol/l, baseline vs fasted, respectively; p=
0.066) were both decreased upon fasting. Norepinephrine
concentrations were similar (0.97±0.45 vs 0.95±0.40 nmol/
Table 1 Plasma hormone and metabolite concentrations at thermoneutral temperature and during mild cold exposure, in the baseline vs fasted
condition
Variable Baseline Fasted
Thermoneutral Mild cold Thermoneutral Mild cold
NEFA (μmol/l) 600±221 815±200† 1,172±284*** 1,588±529***, †
Glucose (mmol/l) 5.0±0.3 5.0±0.3 3.9±0.5*** 3.9±0.5***
Insulin (pmol/l) 51.4±22.9 56.3±20.1 38.9±16.7 44.4±11.8
Norepinephrine (nmol/l) 0.97±0.45 2.52±1.18†† 0.95±0.40 3.57±2.11††
Epinephrine (nmol/l) 0.18±0.11 0.19±0.09 0.25±0.15 0.35±0.23†
TSH (mU/l) 2.0±1.0 1.9±1.1† 1.1±0.6** 1.3±0.7
Free T4 (pmol/l) 14.5±1.5 14.6±1.8 14.1±2.2 14.7±2.2†
**p<0.01, baseline vs fasted
***p<0.001, baseline vs fasted
† p<0.05, mild cold vs thermoneutral
†† p<0.01, mild cold vs thermoneutral
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l, baseline vs fasted, respectively; p=0.90), while epinephrine
concentrations tended to be higher upon fasting (0.18±0.11 vs
0.25±0.15 nmol/l, baseline vs fasted respectively; p=0.07).
Changes in energy expenditure upon fasting Energy expen-
diture was significantly increased upon mild cold exposure in
both the baseline (from 4.6±0.6 to 5.2±0.9 kJ/min, p<0.01)
and the fasted condition (from 4.9±0.8 to 5.2±0.9 kJ/min,
p<0.01). NST, expressed as percentage increase in energy
expenditure upon cold exposure, was significantly lower in
the fasted condition (12.7±9.1% vs 6.7±5.1%, p<0.01;
Table 2 and Fig. 2d). In addition, the absolute increase in
energy expenditure upon cold exposure was significantly
lower upon fasting (0.6±0.5 vs 0.3±0.3 kJ/min, baseline vs
fasted respectively; p<0.05). However, since BMR showed a
slight increase upon fasting (∼6%, p<0.01), total whole-body
energy expenditure during cold exposure was similar between
fasting and baseline conditions (p>0.05).
The respiratory quotient (RQ) was significantly lower upon
fasting (Table 2). Cold exposure elicited no significant change
in RQ or plasma glucose levels in either condition, while it
increased plasma NEFAs in both conditions (Table 1).
Decreased BAT glucose uptake upon fasting In the baseline
condition, cold-induced BATactivity was detected in 15 out of
16 participants. Average [18F]FDG uptake (SUV mean) of all
upper body BAT depots was 2.3±0.8 and maximal [18F]FDG
uptake (SUV max) in BAT was 10.6±6.5. There were no
significant differences in BAT glucose uptake between males
and females, which is in accordance with previous findings
[22, 30]. Outdoor temperature did not affect cold-stimulated
BATactivity. We could detect BAT activity upon fasting in 14
out of the 15 participants that also showed BAT activity at
baseline. However, fasting resulted in a marked decrease in
cold-induced glucose uptake in BAT: average BAT [18F]FDG
uptake decreased to 1.7±0.7 SUV and maximal [18F]FDG
uptake decreased to 4.7±4.4 SUV (both p<0.01 compared
with baseline condition; Table 2). Analysis of dynamic PET/
CT imaging of the supraclavicular region revealed similar
results. The average supraclavicular BAT glucose uptake rate
of all participants was 6.0±3.4 μmol min−1 100 g−1 in the
baseline condition, and decreased to 2.7±1.7 μmol min−1
100 g−1 upon fasting (p<0.001, Fig. 2a–c).
To investigate glucose fluxes into BAT upon fasting in
more detail, two-tissue compartment modelling of the dynam-
ic PET/CT data was employed (ESM Fig. 1). K1 values,
representing the [18F]FDG influx rate constant from plasma
into BAT (including both interstitial and intracellular space),
were not different between the baseline and fasted condition
(0.09±0.04 vs 0.11±0.03 ml min−1 ml−1, respectively, p=
0.146; Table 3). In addition, the distribution volume (DV) of
free (nonphosphorylated) [18F]FDG in BATwas not different
between the baseline and fasted condition (0.32±0.13 vs
0.26±0.09 ml/ml, respectively, p=0.185). Interestingly, phos-
phorylation fraction value, reflecting the proportion of
[18F]FDG that enters the tissue (including both interstitial
Table 2 BAT activity and energy expenditure during baseline and fasted conditions
Variable Group values (n=16) Males (n=8) Females (n=8)
Baseline Fasted Baseline Fasted Baseline Fasted
[18F]FDG uptake in BAT (SUV mean) 2.3±0.8 1.7±0.7** 2.6±0.6 1.8±0.8* 2.1±0.9 1.7±0.7*
[18F]FDG uptake in BAT (SUV max) 10.6±6.5 4.7±4.4** 12.5±7.6 5.5±5.8 8.7±5.0 3.9±2.5*
Glucose uptake rate in BAT (μmol min−1 100 g−1) 6.0±3.4 2.7±1.7** 7.3±3.8 2.8±2.1* 4.8±2.5 2.5±1.4*
Fixed volume analysis
[18F]FDG uptake in BAT (SUV mean) 7.4±5.0 3.0±2.6** 8.7±6.1 3.3±3.4 5.9±3.5 2.6±1.6*
Glucose uptake rate in BAT (μmol min−1 100 g−1) 17.3±14.3 4.8±5.4** 20.4±17.8 4.8±7.2 10.3±6.9 3.8±3.2*
Energy expenditure (kJ/min)
Thermoneutral 4.6±0.6 4.9±0.8** 5.1±0.5 5.5±0.5** 4.2±0.3‡ 4.3±0.3‡
Mild cold 5.2±0.9† 5.2±0.9† 6.0±0.6† 6.0±0.5† 4.5±0.4†, ‡ 4.5±0.4†, ‡
% NST 12.7±9.1 6.7±5.1** 14.8±12.5 10.2±5.1* 7.9±5.6 4.6±4.8
RQ
Thermoneutral 0.80±0.04 0.74±0.03** 0.82±0.05 0.75±0.04* 0.80±0.04 0.75±0.03**
Mild cold 0.81±0.04 0.76±0.04** 0.81±0.04 0.76±0.04* 0.81±0.03 0.78±0.05*
*p<0.05, baseline vs fasted
**p<0.01, baseline vs fasted
† p<0.05, mild cold vs thermoneutral
‡ p<0.05 males vs females
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and intracellular space) that is eventually metabolised (k3/
[k2+k3]), was significantly lower upon fasting (0.25±0.11
vs 0.11±0.06, baseline vs fasted, respectively, p<0.01).
BAT glucose uptake rate and NST were significantly cor-
related in the baseline condition (Fig. 2e), as were maximal
[18F]FDG uptake in BAT and NST (Fig. 2f). Changes in NST
and BAT glucose uptake from the baseline to the fasting
condition were not related.
Glucose uptake in other tissues In contrast to marked de-
creases in [18F]FDG uptake in BAT, no changes in
[18F]FDG uptake during cold stimulation were observed in
skeletal muscle, visceral WAT, liver and brain in the fasted
compared with the baseline condition (Fig. 3). Subcutaneous
WAT showed a small but significant increase in cold-
stimulated glucose uptake upon fasting (0.21±0.07 to 0.26±
0.09 SUV mean, p<0.05).
Skeletal muscle mitochondrial respiration Next to BAT, skel-
etal muscle is a putative alternative contributor to NST via
mitochondrial proton leak, resulting in respiration that is not
coupled to ATP production [31]. Analysis of mitochondrial
oxygen consumption using isolated mitochondria revealed no
differences in oligomycin-insensitive (state 4o) respiration,
reflecting basal proton leak, between the baseline and fasted
samples (175.0±68.7 vs 164.5±63.1 pmol O2 s
−1 mg−1 mito-
chondrial protein, respectively, p>0.05; ESM Fig. 2a), indi-
cating no contribution of skeletal musclemitochondrial proton
leak to the decrease in NST upon fasting. Fatty acids stimu-
lated the oligomycin-insensitive (state 4o) respiration in a
a b










































































Fig. 2 BAT glucose uptake rate and NST are significantly decreased
upon fasting. A significant association between BAT activity and NST is
found in the baseline condition. (a) [18F]FDG-PET images after cold
exposure in a female participant in the baseline (left) and fasted (right)
condition. Black arrows indicate supraclavicular BAT activity. (b) Trans-
versal CT, PET and PET/CT fusion slices (as indicated) of the
supraclavicular region showing [18F]FDG uptake in BAT locations (white
arrows) after cold exposure in the baseline and the fasted condition. (c, d)
Individual data on BAT glucose uptake rate and NST (%). (e, f) Associ-
ations between NST (%) and BAT glucose uptake rate (r2=0.347,
p<0.05), and between NST (%) and maximal BAT activity (BAT SUV
max; r2=0.356, p<0.05) in the baseline condition
Table 3 Rate constants for two-tissue compartment modelling of
[18F]FDG metabolism in BAT
Baseline Fasted
K1, ml min





DVof free [18F]FDG (K1/k2),
ml plasma/ml tissue
0.32±0.13 0.26±0.09
Phosphorylation fraction [k3/(k2+k3)] 0.25±0.11 0.11±0.06**





























Fig. 3 Mean (± SEM) uptake of [18F]FDG in BAT and other tissues
during the baseline (white bars) and fasted (black bars) conditions.
*p<0.05 fasted vs baseline. SM, skeletal muscle; WATs, subcutaneous
white adipose tissue; WATv, visceral white adipose tissue. n=16 (for
brain n=9)
Diabetologia (2015) 58:586–595 591
dose-dependent manner. However, calculated half-maximal
effective concentration (EC50) values (278±236 vs 235±
194 nmol/l, baseline vs fasted, respectively, p>0.05; ESM
Fig. 2b) and maximal fatty acid-induced uncoupled respira-
tion values (Vmax; 2,486±690 vs 2,082±818 pmol
O2 s
−1 mg−1, baseline vs fasted, respectively, p>0.05; ESM
Fig. 2c) were similar in both conditions, indicating compara-
ble sensitivity to the uncoupling effects of fatty acids in the
baseline and fasted condition.
Core and skin temperatures and skin perfusion Temperature
of the water-perfused suit showed a similar decrease during the
cooling protocol in the baseline (from 30.3±0.6°C to 25.4±
0.8°C) and the fasted condition (from 30.3±0.5°C to 25.6±
0.9°C). Consequently, the decrease in mean skin temperature
during the cooling protocol was also similar between condi-
tions (−3.9±0.9°C vs −3.9±1.0°C, p=0.628, respectively;
Table 4). In addition, skin perfusion of the hand and abdomen
were not different between the conditions. Interestingly, core
temperature showed a significant decrease upon cold exposure
in the fasted condition (−0.26±0.21°C, p<0.001), in contrast
to an unchanged core temperature in the baseline condition
(0.04±0.24°C, p=0.557). The difference in cold-induced core
temperature between the fasted and the baseline condition was
significantly correlated to the difference in BAT glucose up-
take rate (r2=0.350, p<0.05; Fig. 4) and BAT phosphorylation
fraction (r2=0.308, p<0.05) between these conditions.
Discussion
BAT has been proposed as a target to stimulate glucose
disposal under insulin-resistant conditions, such as type 2
diabetes. When peripheral tissues are resistant for the effect
of insulin to stimulate glucose uptake, this leads to impaired
insulin-induced glucose clearance. However, even under such
insulin-resistant conditions, glucose uptake in peripheral tis-
sues can still be increased via non-insulin dependent
pathways, such as the AMPK pathway that can be activated
by exercise or by pharmacological means [32]. Whether cold-
induced activation of BAT could also be a target to improve
glucose clearance under insulin-resistant conditions in
humans is so far unknown. Here we used prolonged fasting
as a model to induce insulin resistance, and examined whether
cold stimulation could still activate glucose uptake into BAT
under such insulin-resistant conditions. Prolonged fasting is
an interesting model, as peripheral insulin resistance develops
to preserve glucose as a substrate for the brain; however, even
under hyperinsulinaemic–euglycaemic clamp conditions,
when glucose availability is ample, peripheral glucose uptake
is still reduced after 60 h of fasting, as we have shown recently
[18]. Although we were not able to repeat measurements of
whole-body insulin resistance here, we followed a very sim-
ilar protocol as in our previous publication and levels of
plasma NEFAs, glucose and insulin are in agreement with this
previous study, convincing us that participants were indeed
more insulin-resistant upon fasting in the present study. We
now show that cold-induced glucose uptake into BAT is
markedly reduced after prolonged fasting. If these results
also apply to other insulin-resistant conditions, it may
suggest that isolated cold therapy may not be able to
improve glucose homeostasis via glucose clearance by
BAT under such conditions.
Table 4 Body temperatures and skin perfusion at thermoneutral temperature and during mild cold exposure, in the baseline vs fasted condition
Variable Baseline Fasted
Thermoneutral Mild cold Delta Thermoneutral Mild cold Delta
Core temperature (°C) 37.06±0.26 37.10±0.24 0.04±0.24 37.22±0.28** 36.96±0.29*,†† −0.26±0.21**
Mean skin temperature (°C) 35.4±0.2 31.4±0.8†† −3.9±0.9 35.5±0.3 31.6±1.0†† −3.9±1.0
Skin perfusion hand relative % 100 14.6±10.0†† −85.4±10.0 100 15.3±11.6†† −84.7±11.6
Skin perfusion abdomen relative % 100 76.0±21.4†† −24.0±21.4 100 67.1±15.2†† −32.9±15.2
*p<0.05, baseline vs fasted
**p<0.01, baseline vs fasted

























Fig. 4 Relationship between the difference in core temperature during
cold exposure between the fasted and the baseline condition (Δ core
temperature in mild cold) and the difference in BAT glucose uptake rate
between these conditions (Δ glucose uptake rate); r2=0.350, p<0.05
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The dynamic PET scanning protocol allowed us to inves-
tigate disturbances in cold-induced BAT glucose uptake upon
prolonged fasting in more detail, using two-tissue compart-
ment modelling. Theoretically, decreased glucose uptake rates
into BATcould be either due to decreased glucose availability
to the tissue (e.g. due to decreased blood flow, decreased
plasma glucose or decreased glucose extraction) and/or due
to decreased cellular glucose uptake rate. Interestingly, we
found no significant changes in [18F]FDG influx rates (K1)
and [18F]FDG distribution volume in BAT upon fasting, indi-
cating that the decrease in BAT glucose uptake rate was not
due to a lower supply of glucose towards BAT, i.e. glucose
transport to BAT interstitial space was not hampered. Rather,
the model indicates a lower cellular uptake and/or decreased
phosphorylation rate of glucose, as indicated by the lower
phosphorylation fraction in the fasted condition. As stated
above, it should be noted that glucose transport into BAT
reflects movement of [18F]FDG to both intracellular and in-
terstitial space [33] and that two-tissue compartment model-
ling does not completely discriminate between (GLUT-
mediated) glucose transport into brown adipocytes and/or
subsequent phosphorylation by hexokinase. We are there-
fore not able to distinguish between brown adipocyte
[18F]FDG uptake or [18F]FDG phosphorylation as the
main determinant of decreased BAT [18F]FDG uptake
upon fasting. As in other insulin-resistant conditions
both of these processes are disturbed as well [34]; this
points towards comparable mechanisms at play in BAT
during fasting-induced insulin-resistant conditions.
Interestingly, the decrease in cold-stimulated glucose up-
take after fasting is specific for BAT, since this was not
observed in other tissues. In subcutaneous WAT, [18F]FDG
uptake was increased, which may be explained by an in-
creased triacylglycerol/fatty acid cycling, whereby α-
glycerol phosphate, which provides the backbone for esterifi-
cation of NEFAs, is derived from plasma glucose uptake, as
demonstrated previously [35]. The energy required for this
process might actually contribute to the increase in energy
expenditure that we measured upon fasting [36]. In skeletal
muscle, cold-induced glucose uptake was not affected by
fasting; these results may indicate that even though cold
exposure may not be able to increase glucose clearance under
insulin-resistant conditions via BAT, the effect of cold expo-
sure on other glucose-consuming tissues may still be worth
exploring as a therapy to boost glucose clearance under
insulin-resistant states.
Consistent with previous publications [37, 38], we found
that BMR was increased upon fasting, most likely due to
increased whole-body sympathetic activity, as indicated by
the elevated epinephrine levels. Furthermore, we found that
NST was decreased upon fasting, which can be partly ex-
plained by higher BMR, and we found a correlation between
BAT glucose uptake rate and NST at baseline, but not in the
fasted state. At first instance, this latter finding could argue
against a direct relationship between BAT thermogenic activ-
ity and whole-body energy expenditure. However, it should be
noted that [18F]FDG uptake is not a direct measure of the
thermogenic activity of BAT. Although a relationship between
[18F]FDG uptake and thermogenesis in BATwill apply under
most conditions, a shift in substrate oxidation towards fatty
acid metabolism during fasting might result in increased reli-
ance on fatty acid oxidation for BAT’s heat production. Thus,
using only glucose uptake as a measure of BAT activity could
possibly lead to an underestimation of true BAT thermogen-
esis under fasted conditions. Future studies using alternative
tracers, such as [18F]THA (as a measure of NEFA uptake) and
11C-acetate (as a measure of oxidative metabolism), are need-
ed to determine the thermogenic activity of BAT under
prolonged fasting conditions. Nevertheless, it is interesting
to note that we did find that the fasting-induced decrease in
BAT glucose uptake was related to a decrease in core temper-
ature upon cold exposure. Based on our data, it is therefore
tempting to speculate that, although a reduction in cold-
stimulated glucose uptake into BAT upon fasting may be
beneficial to spare glucose availability for the brain, an im-
paired capacity to regulate body temperature may be the
consequence. To the best of our knowledge, this is the first
study that shows a direct link between changes in BAT glu-
cose uptake and core temperature, indicating a role for BAT in
maintaining core temperature upon cold exposure in humans.
In conclusion, this study shows that under prolonged
fasting-induced insulin-resistant conditions, cold-stimulated
glucose uptake into BAT is reduced, due to a reduced cellular
glucose uptake, and is accompanied with reduced NST.
Furthermore, our data indicate that the decrease in cold-
stimulated BAT glucose uptake upon fasting is related to a
decrease in core temperature during cold exposure, suggesting
a role for BAT in maintaining a constant core temperature in
cold environment. If the observed reduction in the capacity of
BAT to take up glucose upon cold exposure is also applicable
to other insulin-resistant conditions, such as type 2 diabetes,
our data may indicate that a focus on cold-induced stimulation
of BAT alone may not be a valid way to improve glucose
clearance under such conditions. However, follow-up stud-
ies are needed to examine whether glucose uptake into
BAT can be activated by other means under insulin-
resistant conditions. Specifically, studies in type 2 dia-
betic patients are urgently awaited.
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